MacroGenics Inc.
MGNX | NASDAQ
$4.12
-$0.02 (-0.48%)
At close: Sep 21, 2026, 4:00 PM ET
$4.13
+$0.01 (+0.24%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 149.5M | 148.34M | 57.19M | 150.02M | 75.64M | 97.76M |
Cost of Revenue | 43.18M | 12.3M | 8.22M | 7.38M | 2.65M | n/a |
Gross Profit | 106.32M | 136.04M | 48.97M | 142.63M | 72.99M | 97.76M |
Operating Income | -72.84M | -110.58M | -168.24M | -121.42M | -202.8M | -131.06M |
Interest Income | 3.4M | 9.42M | 9.69M | 1.7M | 680K | 800K |
Pretax Income | -75.29M | -66.02M | -9.06M | -119.76M | -202.12M | -129.74M |
Net Income | -74.62M | -66.97M | -9.06M | -119.76M | -202.12M | -129.74M |
Selling & General & Admin | 39.16M | 71.05M | 52.19M | 58.95M | 63.01M | 42.74M |
Research & Development | 140M | 177.19M | 166.58M | 207.03M | 214.58M | 193.2M |
Other Expenses | n/a | -1.62M | -1.56M | -1.92M | -1.8M | -7.12M |
Operating Expenses | 179.16M | 246.62M | 217.22M | 264.05M | 275.79M | 228.82M |
Interest Expense | 8.51M | 1.12M | 1.43M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 222.34M | 258.92M | 225.44M | 271.44M | 278.44M | 228.82M |
Income Tax Expense | -672K | 944K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 63.16M | 62.62M | 61.93M | 61.41M | 59.94M | 52.44M |
Shares Outstanding (Diluted) | 63.16M | 62.62M | 61.93M | 61.43M | 59.94M | 52.44M |
EPS (Basic) | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 | -2.47 |
EPS (Diluted) | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 | -2.47 |
EBITDA | -59.61M | -57.37M | 2.02M | -107.89M | -190.86M | -119.1M |
EBIT | -66.78M | -64.91M | -7.63M | -119.76M | -202.12M | -131.06M |
Depreciation & Amortization | 7.17M | 7.54M | 9.65M | 11.87M | 11.26M | 11.96M |
Add to Watchlist
Select watchlists to add or remove MGNX